NanoSphere Health Sciences, Inc.

As of December 31, 2025, NanoSphere Health Sciences, Inc. carries a market capitalization of 256,880.13, placing it among publicly traded companies globally. Its enterprise value stands at 341,274.59, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, NanoSphere Health Sciences, Inc. has 10.28M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, NanoSphere Health Sciences, Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -4.69, indicating conservative leverage, while an interest coverage ratio of -20.75 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -550.48, reflecting losses generated across the asset base.

As of the close on September 15, 2026, NanoSphere Health Sciences, Inc.'s stock has declined approximately 20.00% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.04.

Over the twelve months ended December 31, 2025, NanoSphere Health Sciences, Inc. generated - - in revenue and converted that into -114,947.53 in net income, yielding earnings per share of -0.01. EBITDA reached -119,355.77, while operating income came in at -245,283.42.

As of December 31, 2025, NanoSphere Health Sciences, Inc. holds 2,587.59 in cash and equivalents against 86,982.06 in total debt, resulting in a net debt position of 84,394.46. Total book value stands at -1.85M, with working capital of -1.85M providing operational flexibility.

NanoSphere Health Sciences, Inc. produced -31,524.44 in operating cash flow over the twelve months ended December 31, 2025.

These figures cover the twelve months ended December 31, 2025. Free cash flow yield is negative at -12.27: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -14.17, meaning NanoSphere Health Sciences, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

NanoSphere Health Sciences, Inc.'s most recent stock split took place on July 7, 2021 with a 20:1 split ratio.

As of December 31, 2025, NanoSphere Health Sciences, Inc. has an Altman Z-Score of -1,907.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.